Topics, Trends & Updates

July 2026

View as web page

YouTube  Facebook  Linkedin  Instagram

Updated: Prevention and Management of Hepatitis A Virus Infection in Adults With HIV

The Prevention and Management of Hepatitis A Virus Infection in Adults With HIV guideline was developed to guide clinicians who provide medical care for adults (aged ≥18 years) with HIV who are at risk of acquiring HAV or have HAV coinfection.


Update by author Dr. Hector I. Ojeda-Martinez and the MCCC:


  • HAV Prevention section: Removed Twinrix as a recommended vaccine for individuals with HIV

Quick Links:

Full Guideline

Printable PDF

Save the Date: PrEP Aware Week 2026

Learn more at prepforsex.org

Hot Topics


See all Hot Topics

Don't Miss

Updated Guidance:

Addressing the Needs of Older Patients and Long-Term Survivors in HIV Care


Updated Guideline:

Mycoplasma genitalium Management in Adults


Viremic—Cases in HIV Podcast

Join Hosts Eileen Scully and Christopher Hoffmann as they present cases, explore quandaries in adult HIV care, and discuss key evidence and guidelines that inform clinical decision-making.



New Episodes

Case 24. A Violaceous Situation: Kaposi Sarcoma: A 42-year-old man with AIDS presents feeling unwell, with white spots in his mouth and scattered violaceous macules on his upper extremities; he has never taken ART. Listen as hosts Eileen Scully and Chris Hoffmann from Hopkins describe their initial work-up for a patient with a CD4 count of 10; discuss symptoms, diagnosis, and treatment of Kaposi sarcoma and other HHV8-related diseases; and remember the historical stigma of KS and the lingering effects of that stigma as they confirm the need to remain KS-aware even in 2026 in the United States. Listen Now

Case 25. A Few of Our Favorite Vaccines: A new-to-you patient—51-yr-old man with HIV since the early 2000s—has spotty vaccine records. How to educate, make recommendations, and avoid too many vaccinations at once? Listen as Chris and Eileen from Johns Hopkins make the case argue for their favorite vaccines among the many recommended for adults with HIV and describe their approaches to patient education, prioritizing based on specific patient needs, and strategizing vaccination schedules. Listen Now

Viremic will be on summer hiatus during July. Catch up on missed cases before we return in August with a brand-new season!

We’re open to suggestions! To submit a clinical topic for a Viremic case discussion, email us at viremicpodcast@jh.edu.

Conversations With CEI Podcast

Compassion, Choice and Curiosity: Harm Reduction in Practice: Harm reduction is a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. It is also a movement for social justice built on a belief in, and respect for, the rights of people who use drugs. Although harm reduction was introduced as a U.S. Federal Drug Policy Priority in 2022, it’s currently facing funding cuts that threaten life-saving resources and services. In this episode, we’ll hear from harm reductionist Giorgio Handman, who has over 15 years of experience advocating for and implementing harm reduction to support New Yorkers. He will share his personal experience with harm reduction and talk about the evolution and future of harm reduction. Listen Now


Closer to a Cure? New HIV Cure Research from Stem Cell Transplants to CAR-T Cell Therapy: Two recent studies have shown remarkable advances in HIV cure research: (1) a Norwegian man who achieved long-term HIV remission after a stem cell transplant from his brother, and (2) a Phase 1 trial testing CAR-T cell therapy. On this episode, Antonio Urbina, MD, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellence, dives into these studies and puts them into clinical context, including how to discuss cure research with patients. Listen Now

Upcoming Training, Education, and Events

CEI:


See all


General:


See all

Are You a Subscriber?



If this newsletter was forwarded to you, please subscribe now to make sure you receive the Clinical Guidelines Program Topics, Trends, and Updates newsletter every month and stay current with new and updated guidelines. We send 1 email per month and do not share our mailing list.

Comments? Questions? Suggestions?


Email us: aiguidelines@jhmi.edu. 

We'll get back to you as quickly as possible.


Note that we cannot answer questions about the care or treatment of specific patients and cannot provide clinical advice.